| Literature DB >> 25705242 |
Michaela Hau1, Mark F Haussmann2, Timothy J Greives3, Christa Matlack2, David Costantini4, Michael Quetting1, James S Adelman5, Ana Catarina Miranda6, Jesko Partecke7.
Abstract
BACKGROUND: Individuals of the same age can differ substantially in the degree to which they have accumulated tissue damage, akin to bodily wear and tear, from past experiences. This accumulated tissue damage reflects the individual's biological age and may better predict physiological and behavioural performance than the individual's chronological age. However, at present it remains unclear how to reliably assess biological age in individual wild vertebrates.Entities:
Keywords: Biomarker; Eurasian blackbird; Glucocorticoid; Oxidative stress; Repeated stressors; Telomere
Year: 2015 PMID: 25705242 PMCID: PMC4336494 DOI: 10.1186/s12983-015-0095-z
Source DB: PubMed Journal: Front Zool ISSN: 1742-9994 Impact factor: 3.172
Figure 1Timeline of experiment. Treatment types: LPS: LPS injections, Chron. dist.: chronic disturbance. Biomarker sampling: Tel: telomeres, OX: oxidative stress, HPA: glucocorticoid hormones, CYT: cytokines.
Figure 2Long-term effects of treatment on potential biomarkers. (a) Telomere length, (b) plasma oxidative damage, (c) plasma non-enzymatic antioxidant capacity, (d) red blood cell glutathione peroxidase, (e) Scaled Mass Index, (f) locomotor activity, and plasma concentrations of (g) baseline corticosterone, (h) stress-induced corticosterone, (i) difference in corticosterone between stress-induced levels and concentrations after injection of dexamethasone (please note that positive values indicate strong (+) negative feedback whereas negative values show weak (−) negative feedback , see also arrow), (k) corticosterone after injection of ACTH. Open circles: control group (n = 20), filled circles: stress-exposed group (n = 12). All data are mean ± 1SEM. Results as derived from LMMs (see text): * interaction time*treament p < 0.05, ^ treatment p < 0.05, # time p < 0.05.
Effects of treatment on potential biomarkers
|
|
|
| |
|---|---|---|---|
| Genome-wide telomere length (bp) | p > 0.28 |
|
|
| Plasma oxidative damage (mM H2O2 equivalents) | p > 0.2 |
|
|
| Plasma non-enzymatic antioxidants (mM HOCl neutralized) | p > 0.1 |
| p > 0.3 |
| Glutathione peroxidase (U/l hemolysate) | p > 0.1 |
| p > 0.26 |
| Scaled mass index | p > 0.12 | F(1,32) = 3.65, p = 0.065 | p > 0.7 |
| Locomotor activity (hops/min.) |
| p > 0.1 |
|
| Baseline corticosterone (ng/ml) | p > 0.7 | p > 0.3 | p > 0.5 |
| Stress-induced corticosterone (ng/ml) | p > 0.3 | p > 0.4 | p > 0.8 |
| Difference between stress-induced corticosterone and concentrations after dexamethasone injection (ng/ml) | p > 0.1 | p > 0.6 | p > 0.7 |
| Corticosterone after ACTH injection (ng/ml) | p > 0.5 | p > 0.09 | p > 0.6 |
Effects of stress-exposure (repeated LPS injections and 10-day chronic disturbance protocols combined) on potential biomarkers (all log-transformed) assessed at the beginning and the end of the experiment, as determined from LMM statistics (for details see text). Significant effects are highlighted in bold. Data are shown in Figure 2.